
The Mesothelioma Center News – Page 29
-
newsAsbestos Exposure & BansThe Scientific Analytical Institute in Greensboro, North Carolina, recently uncovered asbestos-contaminated talc in two new eyeshadow makeup products sold online on sites like Amazon…
-
newsAsbestos Exposure & Bans
Libby Protects Those with Asbestos Disease from COVID-19
No town in America has a higher percentage of asbestos-related lung disease — and resulting respiratory issues — than Libby, Montana, making its… -
newsAsbestos Exposure & Bans
Report Finds Asbestos, Other Risks in Military Family Housing
U.S. military families around the world are living in government-owned and -operated housing containing serious health and safety risks, according to the most recent… -
newsTreatment & Doctors
UK Oncologist Proposes Novel Treatment for Mesothelioma
Medical oncologist Dr. Angus Dalgleish never did like standard of care treatment for pleural mesothelioma cancer, even when he reluctantly recommended it in… -
newsResearch & Clinical Trials
COVID-19 Pandemic Delays Mesothelioma Clinical Trials
Medical centers across the country have slowed or stopped the enrollment of new patients in mesothelioma clinical trials because of the all-consuming COVID-19… -
newsAsbestos Exposure & Bans
US Asbestos Imports Dropped Significantly in 2019
Raw asbestos imported to the United States dropped significantly in 2019, according to the recently released U.S. Geological Survey Mineral Commodity Summaries report. The… -
newsResearch & Clinical Trials
Promising Data Supports Curcumin Treatment for Mesothelioma
The plant-based substance curcumin could soon be included in the multidisciplinary treatment of malignant mesothelioma, according to a recent multicenter, international study review. Curcumin,… -
newsResearch & Clinical Trials
UPenn Research with Mesothelioma Blood Test Shows Promise
Scientist Ian Blair at the University of Pennsylvania School of Medicine believes his team is close to identifying the variant of a blood-based biomarker… -
newsResearch & Clinical Trials
Mesothelioma Clinical Trial Testing New INBRX-109 Antibody
A new clinical trial is testing an innovative approach to immunotherapy that could change the way antibodies target pleural mesothelioma tumors. Researchers at… -
newsTreatment & Doctors
Coronavirus Postpones Mesothelioma Symposium
The Mesothelioma Applied Research Foundation has postponed its annual International Symposium on Malignant Mesothelioma next month because of the COVID-19 virus, commonly known as…